GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Paincare Holdings Ltd (SGX:FRQ) » Definitions » YoY EBITDA Growth

Singapore Paincare Holdings (SGX:FRQ) YoY EBITDA Growth : -11.11% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Singapore Paincare Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Singapore Paincare Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -11.11%.

Singapore Paincare Holdings's EBITDA per Share for the six months ended in Dec. 2024 was S$0.02.


Singapore Paincare Holdings YoY EBITDA Growth Historical Data

The historical data trend for Singapore Paincare Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore Paincare Holdings YoY EBITDA Growth Chart

Singapore Paincare Holdings Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EBITDA Growth
Get a 7-Day Free Trial 133.33 - 71.43 -50.00 94.44

Singapore Paincare Holdings Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.22 -77.78 28.57 325.00 -11.11

Singapore Paincare Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Singapore Paincare Holdings's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (A: Jun. 2024 )
=(EBITDA per Share (A: Jun. 2024 )-EBITDA per Share (A: Jun. 2023 ))/ | EBITDA per Share (A: Jun. 2023 ) |
=(0.035-0.018)/ | 0.018 |
=94.44 %

Singapore Paincare Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.016-0.018)/ | 0.018 |
=-11.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Singapore Paincare Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Singapore Paincare Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Singapore Paincare Holdings Business Description

Traded in Other Exchanges
N/A
Address
601 Macpherson Road, No. 06-20/21 Grantral Mall, Singapore, SGP, 368242
Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, and primary care and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company derives its revenue from Singapore.

Singapore Paincare Holdings Headlines

No Headlines